Biodyne

바이오다인 · 314930

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$209.4M (₩289B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$5.1M
▲ +33.3% YoY
Operating profit · FY2025
US$472.7K
Turned profitable
Net income · FY2025
US$617.1K
▲ +7807.0% YoY

Revenue

  • FY2023US$3M
  • FY2024US$3.8M
  • FY2025US$5.1M

Operating profit

  • FY2023−US$1.5M
  • FY2024−US$1.3M
  • FY2025US$472.7K

Net income

  • FY2023−US$718.7K
  • FY2024US$7.8K
  • FY2025US$617.1K

Key ratios (FY2025)

ROE
1.9%
Debt/Eq
2.0%
Op. margin
9.3%
Net margin
12.1%
Rev. YoY
▲ +33.3%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.